TRLV (Trulieve Cannabis) Cyclically Adjusted PS Ratio: (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TRLV Trulieve Cannabis Corp TRLV
68 GF Score
Price $9.08
GF Value $6.44
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Trulieve Cannabis Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Trulieve Cannabis  (NYSE:TRLV) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Trulieve Cannabis Cyclically Adjusted PS Ratio Related Terms


Trulieve Cannabis Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Trulieve Cannabis's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trulieve Cannabis Cyclically Adjusted PS Ratio Chart

Trulieve Cannabis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.62

Trulieve Cannabis Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1.62 0.00 0.00

TRLV vs ANIP, XERS, HROW: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trulieve Cannabis Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Trulieve Cannabis's Cyclically Adjusted PS Ratio falls into.


TRLV
68GF Score
Trulieve Cannabis Corp TRLV
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trulieve Cannabis Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Trulieve Cannabis's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Trulieve Cannabis's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.406/333.9520*333.9520
=1.406

Current CPI (Jun. 2026) = 333.9520.

Trulieve Cannabis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 0.000 246.524 0.000
201803 0.000 249.554 0.000
201806 0.000 251.989 0.000
201809 0.284 252.439 0.376
201812 0.314 251.233 0.417
201903 0.385 254.202 0.506
201906 0.501 256.143 0.653
201909 0.642 256.759 0.835
201912 0.609 256.974 0.791
202003 0.834 258.115 1.079
202006 1.047 257.797 1.356
202009 1.155 260.280 1.482
202012 1.344 260.474 1.723
202103 1.519 264.877 1.915
202106 1.617 271.696 1.988
202109 1.637 274.310 1.993
202112 1.539 278.802 1.843
202203 1.699 287.504 1.973
202206 1.677 296.311 1.890
202209 1.566 296.808 1.762
202212 1.576 296.797 1.773
202303 1.510 301.836 1.671
202306 1.491 305.109 1.632
202309 1.457 307.789 1.581
202312 1.518 306.746 1.653
202403 1.571 312.332 1.680
202406 1.594 314.175 1.694
202409 1.495 315.301 1.583
202412 1.585 315.605 1.677
202503 1.558 319.799 1.627
202506 1.580 322.561 1.636
202509 1.507 324.800 1.549
202512 1.529 324.054 1.576
202603 1.450 330.213 1.466
202606 1.406 333.952 1.406

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Trulieve Cannabis (TRLV) Overvalued in 2026?

Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued. The current stock price of $9.08 is trading 41% above its estimated GF Value™ of $6.44. GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.

Key valuation signals for TRLV:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $6.44 vs. price of $9.08 (41% above fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the TRLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Trulieve Cannabis Business Description

Other Exchanges T0A:GermanyTRUL:Canada
Address 3494 Martin Hurst Road, Tallahassee, FL, USA, 32312
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
68GF Score

Get the complete analysis for TRLV

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.08
Price
$6.44
GF Value